Peripartum kardiomyopati
Research output: Contribution to journal › Journal article › Research › peer-review
Peripartum cardiomyopathy is a rare and potentially fatal disease with peripartum heart failure in previously healthy women. A brief review of the literature is provided with emphasis on recent data indicating that an antiangiogenic cleavage product of prolactin contributes to the molecular mechanisms underlying peripartum cardiomyopathy, and that blocking the release of prolactin with bromocriptine can ameliorate the condition.
Translated title of the contribution | Peripartum cardiomyopathy |
---|---|
Original language | Danish |
Journal | Ugeskrift for læger |
Volume | 171 |
Issue number | 1-2 |
Pages (from-to) | 53-5 |
Number of pages | 3 |
ISSN | 0041-5782 |
Publication status | Published - 5 Jan 2009 |
Bibliographical note
Keywords: Bromocriptine; Cardiomyopathies; Female; Hormone Antagonists; Humans; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Risk Factors
ID: 19867482